Search Results  for '4107.TWO'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Bioteque Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

04 Jul 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Bioteque Corp (4107-OT)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

07 Jul 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Bioteque Corporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

17 Jun 2015 Wright Reports 56 $75.00

Will Bioteque Corporation Deliver Long-Term Returns?

13 May 2015 Sadif Analytics Prime 12 $25.00

Bioteque Corporation (4107) - Financial Analysis Review

Bioteque Corporation (4107) - Financial Analysis Review Summary BIOTEQUE CORPORATION (BIOTEQUE) is a medical device com...

07 May 2015 GlobalData 20 $125.00

邦特(4107.TT)4月營收登高可期且營運動能優於預期 維持買進並調升目標價

營運動能優於預期,維持買進並調升目標價:研調處維持邦特買進建議,主因(1)四月營收隨菲律賓廠開始出貨下可望再創新高;(2)公司產品出貨訂單調配得宜,毛利率表現優於預期;(3)隨台菲廠區產能移轉下,營收及毛利率將持續走高,強勁成長動能也可延續,維持買進...

30 Apr 2015 SinoPac Sec Investment Service Traditional Chinese 5 $35.00

邦特(4107.TT)菲律賓新廠啟動在即,2Q營運加溫可期,維持買進

菲律賓新廠啟動在即,2Q營運加溫可期,維持買進:由於菲律賓新廠已達最後可出貨階段,此將使邦特業績2Q起持續增溫,加以隨產線擴充與優化雙軌並行下,未來數年整體獲利可望延續強勁成長動能,維持買進建議,目標價88元(20 X 2015EPS),潛在上漲空間...

13 Mar 2015 SinoPac Sec Investment Service Traditional Chinese 5 $35.00

Is There Long-Term Value in Bioteque Corporation?

18 Feb 2015 Sadif Analytics Prime 12 $25.00

Bioteque Corporation (4107) - Financial Analysis Review

Bioteque Corporation (4107) - Financial Analysis Review Summary BIOTEQUE CORPORATION (BIOTEQUE) is a medical device com...

09 Feb 2015 GlobalData 20 $125.00

邦特(4107.TT)菲律賓新廠效應2Q將啟動,維持買進

菲律賓新廠效應2Q將啟動,維持買進:投資建議方面,由於邦特在產線配置得宜且客戶需求穩固下,業績穩健成長態勢確立,且菲律賓新廠效應啟動在即,公司中長期動能值得期待,維持買進,惟目標價因獲利之調整由94元降至88元(PER=20X2015EPS)。

09 Jan 2015 SinoPac Sec Investment Service Traditional Chinese 5 $35.00